Bionano Genomics (BNGO) Short-term Investments (2021 - 2026)

Bionano Genomics' Short-term Investments history runs 6 years deep, the most recent figure standing at $11.0 million for Q1 2026.

• In Q1 2026, Short-term Investments fell 24.83% year-over-year to $11.0 million; the TTM figure through Mar 2026 stood at $11.0 million (down 24.83% YoY), while the FY2025 annual figure was $16.3 million, up 5290.4% from the prior year.
• Short-term Investments came in at $11.0 million for Q1 2026 at Bionano Genomics, down from $16.3 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $192.4 million in Q1 2022 to a low of $302000.0 in Q4 2024.
• A 5-year average of $51.3 million and a median of $15.4 million in 2025 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments sank 99.14% in 2024 and soared 5290.4% in 2025, its largest moves.
• Bionano Genomics' Short-term Investments stood at $152.0 million in 2022, then tumbled by 76.9% to $35.1 million in 2023, then tumbled by 99.14% to $302000.0 in 2024, then jumped by 5290.4% to $16.3 million in 2025, then sank by 32.55% to $11.0 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $11.0 million, $16.3 million, and $10.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison